Osteoporosis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for osteoporosis. 20 active patents protecting 3 drugs from 2+ originators. First major cliff: 2028. Daily refresh.

3
Approved drugs
20
Active US patents
58/100
Avg vulnerability
—
Annual revenue covered

Originators in Osteoporosis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Radius 9 patents Novartis 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating osteoporosis. Each bar = one year. Y-axis scaled to peak year (8 patents).

2
27
3
28
2
31
8
37
3
38
2
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Tymlos
ABALOPARATIDE
 Radius 9 65 — 2027-10-03
Calcium Gluconate
CALCIUM GLUCONATE
 — 8 45 — 2037-07-25
Zometa
ZOLEDRONIC ACID
 Novartis 3 65 — 2028-02-05

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
RE49444 Tymlos method of use 76 2031-04-28
8748382 Tymlos method of use 75 2027-10-03
7932241 Zometa other 75 2028-08-05
11782041 Tymlos method of use 70 2038-04-30
11255842 Tymlos method of use 70 2040-01-10
11680942 Tymlos method of use 70 2040-01-10
7803770 Tymlos method of use 68 2031-04-28
7932241 Zometa formulation 60 2028-02-05
7932241 Zometa formulation 60 2028-02-05
8148333 Tymlos formulation 55 2027-11-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10996208 Tymlos formulation 42 2038-04-30
10342813 Calcium Gluconate formulation 42 2037-07-25
10130646 Calcium Gluconate formulation 42 2037-07-25
10342813 Calcium Gluconate formulation 42 2037-07-25
10130646 Calcium Gluconate formulation 42 2037-07-25
10342813 Calcium Gluconate formulation 42 2037-07-25
10130646 Calcium Gluconate formulation 42 2037-07-25
11977067 Tymlos formulation 55 2038-04-30
10130646 Calcium Gluconate formulation 55 2037-07-25
10130646 Calcium Gluconate formulation 55 2037-07-25

Related